ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
2 announcements with these filters
Piramal Pharma disclosed that the US FDA has successfully completed its inspection of the Sellersville manufacturing facility. The clearance affirms compliance and operational continuity.
Piramal Pharma Limited successfully closed its US FDA inspection at its Lexington, USA manufacturing facility. The US FDA issued an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) classification. This marks the formal and successful conclusion of the inspection initiated in December 2025.